Head and Neck Cancer
10
Page 1 of 1
| A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer (ECOG E1305) Disease/Condition: Head and Neck Cancer Principal Investigator: Hari Anant Deshpande |
| Cetuximab and Radiation Therapy in Head and Neck Cancer Disease/Condition: Head and Neck Cancer Principal Investigator: Roy Decker |
| Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Disease/Condition: Head and Neck Cancer Principal Investigator: Daniel Morgensztern |
Page 1 of 1
